Revision of sex hormone replacement therapy for CKD Pediatric cases.

Autor: Amirkashani, Davoud, Madani, Sedigheh
Předmět:
Zdroj: Journal of Diabetes & Metabolic Disorders; Jun2023, Vol. 22 Issue 1, p897-898, 2p
Abstrakt: In CKD children who received GH from late pre-pubertal stage, GH therapy had no overall effect on the improvement of pubertal height gain and they still had a prominent height deficit [[8], [10]]. Keywords: Growth retardation; Delayed puberty; GH treatment; Estrogen replacement therapy; Chronic kidney disease EN Growth retardation Delayed puberty GH treatment Estrogen replacement therapy Chronic kidney disease 897 898 2 05/30/23 20230601 NES 230601 Supplementary information The online version contains supplementary material available at https://doi.org/10.1007/s40200-022-01039-7. Although complex medical regimens including bicarbonate therapy, iron, erythropoietin, salt-water supplementation, and Growth Hormone (GH) can improve final height, however, these children experience progressive height deficit after the age of 6 years compared to their normal counterparts [[2]]. [Extracted from the article]
Databáze: Complementary Index